Ocugen (OCGN)
(Real Time Quote from BATS)
$1.32 USD
0.00 (0.00%)
Updated Sep 18, 2025 02:14 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2025
Time: -- |
9/2025 | $-0.06 | 0.00% |
Earnings Summary
For their last quarter, Ocugen (OCGN) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.06 per share. This reflects a positive earnings surprise of 16.67%. Look out for OCGN's next earnings release expected on November 13, 2025. For the next earning release, we expect the company to report earnings of -$0.06 per share, reflecting a year-over-year decrease of 20%.
Earnings History
Price & Consensus
Zacks News for OCGN
Ocugen (OCGN) Reports Q2 Loss, Misses Revenue Estimates
OCGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Cooper Companies Q1 Earnings Likely to Reflect Seasonal Trends
5 Biotech Breakthrough Stocks to Watch in 2025
OCGN FAQs
Ocugen, Inc. (OCGN) has announced they will report their next quarter earnings on November 13, 2025. For the next earning release, we expect the company to report earnings of $-0.06 per share, reflecting a year-over-year decrease of -20.00%.
Ocugen, Inc. has announced they will report their previous quarter earnings after the close of the market on November 13, 2025.
The Zacks Consensus Estimate for Ocugen, Inc. (OCGN) for the quarter ending September 2025 is $-0.06 a share. We expect Ocugen, Inc. (OCGN) to report earnings in line with the consensus estimate of $-0.06 per share
In the earnings report for the quarter ending in June 2024, Ocugen, Inc. (OCGN) announced earnings of $-0.04 per share versus the Zacks Consensus Estimate of $-0.06 per share, representing a surprise of -33.33%.